Increased Oxidative Stress Induced by Rubus Bioactive Compounds Induce Apoptotic Cell Death in Human Breast Cancer Cells
Varicella-zoster virus glycoproteins: entry, replication, and pathogenesis
The treatment normalized serum corticosterone levels, enhanced central GABA and serotonin concentrations and reduced peripheral inflammation and gut microbiota profiling revealed a reduction in potentially pathogenic genera ( Acinetobacter, Enterococcus, Bacillus ) and increased abundance of beneficial taxa ( Muribaculum, Alistipes, Lactobacillus ), indicating the therapeutic potential of targeted psychobiotic intervention for stress-related disorders (Tyagi et al., 2025)
Pfizer Acquires a GLP-1 Pipeline and Revives FOMO Corporate Strategy Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1 On Monday, Pfizer PFE 0.00% announced it is acquiring Metsera MTSR 0.00% and its obesity pipeline
But it can be an avenue for people who are struggling to get to that next step. This article originally appeared as A Balanced Approach to Weight-Loss Drugs in the March/April 2025 issue of Experience Life.
Both genders may suffer from metabolic issues, including weight gain or loss, which can increase the risk of diabetes and cardiovascular diseases